Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists), PPARδ agonists(Peroxisome proliferator-activated receptor delta agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Discovery | - | 31 May 2023 | |
Cardiovascular Diseases | Discovery | - | 31 May 2023 | |
Digestive System Disorders | Discovery | - | 31 May 2023 | |
Endocrinology and Metabolic Disease | Discovery | - | 31 May 2023 | |
Hypoproteinemia | Discovery | - | 31 May 2023 | |
Inflammation | Discovery | - | 31 May 2023 | |
Neoplasms | Discovery | - | 31 May 2023 | |
Nervous System Diseases | Discovery | - | 31 May 2023 | |
Skin and Musculoskeletal Diseases | Discovery | - | 31 May 2023 |